Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up

Aims In hypertrophic cardiomyopathy (HCM), the following five risk factors have a major role in the primary prevention of sudden death (SD): family history of SD (FHSD), syncope, massive wall thickness (MWTh) >30 mm, non-sustained ventricular tachycardia (nsVT) in Holter monitoring of electrocard...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2010-12, Vol.31 (24), p.3084-3093
Hauptverfasser: Dimitrow, Paweł Petkow, Chojnowska, Lidia, Rudziński, Tomasz, Piotrowski, Walerian, Ziółkowska, Lidia, Wojtarowicz, Andrzej, Wycisk, Anna, Dąbrowska-Kugacka, Alicja, Nowalany-Kozielska, Ewa, Sobkowicz, Bożena, Wróbel, Wojciech, Aleszewicz-Baranowska, Janina, Rynkiewicz, Andrzej, Łoboz-Grudzień, Krystyna, Marchel, Michał, Wysokiński, Andrzej
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3093
container_issue 24
container_start_page 3084
container_title European heart journal
container_volume 31
creator Dimitrow, Paweł Petkow
Chojnowska, Lidia
Rudziński, Tomasz
Piotrowski, Walerian
Ziółkowska, Lidia
Wojtarowicz, Andrzej
Wycisk, Anna
Dąbrowska-Kugacka, Alicja
Nowalany-Kozielska, Ewa
Sobkowicz, Bożena
Wróbel, Wojciech
Aleszewicz-Baranowska, Janina
Rynkiewicz, Andrzej
Łoboz-Grudzień, Krystyna
Marchel, Michał
Wysokiński, Andrzej
description Aims In hypertrophic cardiomyopathy (HCM), the following five risk factors have a major role in the primary prevention of sudden death (SD): family history of SD (FHSD), syncope, massive wall thickness (MWTh) >30 mm, non-sustained ventricular tachycardia (nsVT) in Holter monitoring of electrocardiography, and abnormal blood pressure response to exercise (aBPRE). In HCM, as a genetic cardiac disease, the risk for SD may also exist from birth. The aim of the study was to compare the survival curves constructed for each of the five risk factors in a traditional follow-up model (started at the first presentation of a patient at the institution) and in a novel follow-up model (started at the date of birth). In an additional analysis, we compared the survival rate in three subgroups (without FHSD, with one SD, and with two or more SDs in a family). Methods and results A total of 1306 consecutive HCM patients (705 males, 601 females, mean age of 47 years, and 193 patients were 0.0001), whereas in a traditional method, only four factors predicted SD (except aBPRE). In a novel model of follow-up, FHSD in a single episode starts to influence the prognosis with a delay to the fifth decade of life (P = 0.0007). Multiple FHSD appears to be a very powerful risk factor (P < 0.0001), predicting frequent SDs in childhood and adolescence. Conclusion The proposed concept of a lifelong calculated follow-up is a useful strategy in the risk stratification of SD. Multiple FHSD is a very ominous risk factor with strong impact, predicting frequent SD episodes in the early period of life.
doi_str_mv 10.1093/eurheartj/ehq308
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_818402958</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>818402958</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-3a48d47e39b7de1f1ff82af3d9d1724473a766cbcbcec0490e7cc62df96006aa3</originalsourceid><addsrcrecordid>eNpFkEFv1DAQhS0Eokvhzgn5gjiF2rFjJ9xQVVhEEQeKVPVizdpjJW0SZ-1E7fLr8WqXRWNpDu97T-NHyFvOPnLWiAtcYosQ5_sLbLeC1c_IildlWTRKVs_JivGmKpSqb8_Iq5TuGWO14uolOStZLUWj2Ipsfy3O4UgdwtzSbqTtbsI4xzC1naUWouvCsAtTVnefaOgdjV16oB7sHGKiEQtICfNzezPQER_pEBz2NHg6wFM3QN_9yaoPfR8ei2V6TV546BO-Oe5z8vvL1c3lurj--fXb5efrwkot50KArJ3UKJqNdsg9974uwQvXOK5LKbUArZTd5EHLZMNQW6tK5_O3mAIQ5-TDIXeKYbtgms3QJYt9DyOGJZma15KVTVVnkh1IG0NKEb2ZYr477gxnZt-zOfVsDj1ny7tj-LIZ0J0M_4rNwPsjAMlC7yOMtkv_OaFKofk-qDhwXZrx6aRDfDBKC12Z9e2d-VHxm-_r6i7b_gJ2lZtM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>818402958</pqid></control><display><type>article</type><title>Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Dimitrow, Paweł Petkow ; Chojnowska, Lidia ; Rudziński, Tomasz ; Piotrowski, Walerian ; Ziółkowska, Lidia ; Wojtarowicz, Andrzej ; Wycisk, Anna ; Dąbrowska-Kugacka, Alicja ; Nowalany-Kozielska, Ewa ; Sobkowicz, Bożena ; Wróbel, Wojciech ; Aleszewicz-Baranowska, Janina ; Rynkiewicz, Andrzej ; Łoboz-Grudzień, Krystyna ; Marchel, Michał ; Wysokiński, Andrzej</creator><creatorcontrib>Dimitrow, Paweł Petkow ; Chojnowska, Lidia ; Rudziński, Tomasz ; Piotrowski, Walerian ; Ziółkowska, Lidia ; Wojtarowicz, Andrzej ; Wycisk, Anna ; Dąbrowska-Kugacka, Alicja ; Nowalany-Kozielska, Ewa ; Sobkowicz, Bożena ; Wróbel, Wojciech ; Aleszewicz-Baranowska, Janina ; Rynkiewicz, Andrzej ; Łoboz-Grudzień, Krystyna ; Marchel, Michał ; Wysokiński, Andrzej</creatorcontrib><description>Aims In hypertrophic cardiomyopathy (HCM), the following five risk factors have a major role in the primary prevention of sudden death (SD): family history of SD (FHSD), syncope, massive wall thickness (MWTh) &gt;30 mm, non-sustained ventricular tachycardia (nsVT) in Holter monitoring of electrocardiography, and abnormal blood pressure response to exercise (aBPRE). In HCM, as a genetic cardiac disease, the risk for SD may also exist from birth. The aim of the study was to compare the survival curves constructed for each of the five risk factors in a traditional follow-up model (started at the first presentation of a patient at the institution) and in a novel follow-up model (started at the date of birth). In an additional analysis, we compared the survival rate in three subgroups (without FHSD, with one SD, and with two or more SDs in a family). Methods and results A total of 1306 consecutive HCM patients (705 males, 601 females, mean age of 47 years, and 193 patients were &lt;18 years) evaluated at 15 referral centres in Poland were enrolled in the study. In a novel method of follow-up, all the five risk factors confirmed its prognostic power (FHSD: P = 0.0007; nsVT: P &lt; 0.0001; aBPRE: P = 0.0081; syncope: P &lt; 0.0001; MWTh P&gt; 0.0001), whereas in a traditional method, only four factors predicted SD (except aBPRE). In a novel model of follow-up, FHSD in a single episode starts to influence the prognosis with a delay to the fifth decade of life (P = 0.0007). Multiple FHSD appears to be a very powerful risk factor (P &lt; 0.0001), predicting frequent SDs in childhood and adolescence. Conclusion The proposed concept of a lifelong calculated follow-up is a useful strategy in the risk stratification of SD. Multiple FHSD is a very ominous risk factor with strong impact, predicting frequent SD episodes in the early period of life.</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehq308</identifier><identifier>PMID: 20843960</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Age Factors ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Cardiology. Vascular system ; Cardiomyopathy, Hypertrophic - complications ; Cardiomyopathy, Hypertrophic - genetics ; Cardiomyopathy, Hypertrophic - mortality ; Death, Sudden, Cardiac - epidemiology ; Death, Sudden, Cardiac - etiology ; Emergency and intensive care: neonates and children. Prematurity. Sudden death ; Exercise - physiology ; Female ; Heart ; Humans ; Hypertension - etiology ; Hypertension - mortality ; Hypertrophic cardiomyopathy ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Myocarditis. Cardiomyopathies ; Pedigree ; Poland - epidemiology ; Prognosis ; Risk Factors ; Sudden death ; Syncope - etiology ; Syncope - mortality</subject><ispartof>European heart journal, 2010-12, Vol.31 (24), p.3084-3093</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-3a48d47e39b7de1f1ff82af3d9d1724473a766cbcbcec0490e7cc62df96006aa3</citedby><cites>FETCH-LOGICAL-c474t-3a48d47e39b7de1f1ff82af3d9d1724473a766cbcbcec0490e7cc62df96006aa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23623718$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20843960$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dimitrow, Paweł Petkow</creatorcontrib><creatorcontrib>Chojnowska, Lidia</creatorcontrib><creatorcontrib>Rudziński, Tomasz</creatorcontrib><creatorcontrib>Piotrowski, Walerian</creatorcontrib><creatorcontrib>Ziółkowska, Lidia</creatorcontrib><creatorcontrib>Wojtarowicz, Andrzej</creatorcontrib><creatorcontrib>Wycisk, Anna</creatorcontrib><creatorcontrib>Dąbrowska-Kugacka, Alicja</creatorcontrib><creatorcontrib>Nowalany-Kozielska, Ewa</creatorcontrib><creatorcontrib>Sobkowicz, Bożena</creatorcontrib><creatorcontrib>Wróbel, Wojciech</creatorcontrib><creatorcontrib>Aleszewicz-Baranowska, Janina</creatorcontrib><creatorcontrib>Rynkiewicz, Andrzej</creatorcontrib><creatorcontrib>Łoboz-Grudzień, Krystyna</creatorcontrib><creatorcontrib>Marchel, Michał</creatorcontrib><creatorcontrib>Wysokiński, Andrzej</creatorcontrib><title>Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>Aims In hypertrophic cardiomyopathy (HCM), the following five risk factors have a major role in the primary prevention of sudden death (SD): family history of SD (FHSD), syncope, massive wall thickness (MWTh) &gt;30 mm, non-sustained ventricular tachycardia (nsVT) in Holter monitoring of electrocardiography, and abnormal blood pressure response to exercise (aBPRE). In HCM, as a genetic cardiac disease, the risk for SD may also exist from birth. The aim of the study was to compare the survival curves constructed for each of the five risk factors in a traditional follow-up model (started at the first presentation of a patient at the institution) and in a novel follow-up model (started at the date of birth). In an additional analysis, we compared the survival rate in three subgroups (without FHSD, with one SD, and with two or more SDs in a family). Methods and results A total of 1306 consecutive HCM patients (705 males, 601 females, mean age of 47 years, and 193 patients were &lt;18 years) evaluated at 15 referral centres in Poland were enrolled in the study. In a novel method of follow-up, all the five risk factors confirmed its prognostic power (FHSD: P = 0.0007; nsVT: P &lt; 0.0001; aBPRE: P = 0.0081; syncope: P &lt; 0.0001; MWTh P&gt; 0.0001), whereas in a traditional method, only four factors predicted SD (except aBPRE). In a novel model of follow-up, FHSD in a single episode starts to influence the prognosis with a delay to the fifth decade of life (P = 0.0007). Multiple FHSD appears to be a very powerful risk factor (P &lt; 0.0001), predicting frequent SDs in childhood and adolescence. Conclusion The proposed concept of a lifelong calculated follow-up is a useful strategy in the risk stratification of SD. Multiple FHSD is a very ominous risk factor with strong impact, predicting frequent SD episodes in the early period of life.</description><subject>Age Factors</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiomyopathy, Hypertrophic - complications</subject><subject>Cardiomyopathy, Hypertrophic - genetics</subject><subject>Cardiomyopathy, Hypertrophic - mortality</subject><subject>Death, Sudden, Cardiac - epidemiology</subject><subject>Death, Sudden, Cardiac - etiology</subject><subject>Emergency and intensive care: neonates and children. Prematurity. Sudden death</subject><subject>Exercise - physiology</subject><subject>Female</subject><subject>Heart</subject><subject>Humans</subject><subject>Hypertension - etiology</subject><subject>Hypertension - mortality</subject><subject>Hypertrophic cardiomyopathy</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocarditis. Cardiomyopathies</subject><subject>Pedigree</subject><subject>Poland - epidemiology</subject><subject>Prognosis</subject><subject>Risk Factors</subject><subject>Sudden death</subject><subject>Syncope - etiology</subject><subject>Syncope - mortality</subject><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEFv1DAQhS0Eokvhzgn5gjiF2rFjJ9xQVVhEEQeKVPVizdpjJW0SZ-1E7fLr8WqXRWNpDu97T-NHyFvOPnLWiAtcYosQ5_sLbLeC1c_IildlWTRKVs_JivGmKpSqb8_Iq5TuGWO14uolOStZLUWj2Ipsfy3O4UgdwtzSbqTtbsI4xzC1naUWouvCsAtTVnefaOgdjV16oB7sHGKiEQtICfNzezPQER_pEBz2NHg6wFM3QN_9yaoPfR8ei2V6TV546BO-Oe5z8vvL1c3lurj--fXb5efrwkot50KArJ3UKJqNdsg9974uwQvXOK5LKbUArZTd5EHLZMNQW6tK5_O3mAIQ5-TDIXeKYbtgms3QJYt9DyOGJZma15KVTVVnkh1IG0NKEb2ZYr477gxnZt-zOfVsDj1ny7tj-LIZ0J0M_4rNwPsjAMlC7yOMtkv_OaFKofk-qDhwXZrx6aRDfDBKC12Z9e2d-VHxm-_r6i7b_gJ2lZtM</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Dimitrow, Paweł Petkow</creator><creator>Chojnowska, Lidia</creator><creator>Rudziński, Tomasz</creator><creator>Piotrowski, Walerian</creator><creator>Ziółkowska, Lidia</creator><creator>Wojtarowicz, Andrzej</creator><creator>Wycisk, Anna</creator><creator>Dąbrowska-Kugacka, Alicja</creator><creator>Nowalany-Kozielska, Ewa</creator><creator>Sobkowicz, Bożena</creator><creator>Wróbel, Wojciech</creator><creator>Aleszewicz-Baranowska, Janina</creator><creator>Rynkiewicz, Andrzej</creator><creator>Łoboz-Grudzień, Krystyna</creator><creator>Marchel, Michał</creator><creator>Wysokiński, Andrzej</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up</title><author>Dimitrow, Paweł Petkow ; Chojnowska, Lidia ; Rudziński, Tomasz ; Piotrowski, Walerian ; Ziółkowska, Lidia ; Wojtarowicz, Andrzej ; Wycisk, Anna ; Dąbrowska-Kugacka, Alicja ; Nowalany-Kozielska, Ewa ; Sobkowicz, Bożena ; Wróbel, Wojciech ; Aleszewicz-Baranowska, Janina ; Rynkiewicz, Andrzej ; Łoboz-Grudzień, Krystyna ; Marchel, Michał ; Wysokiński, Andrzej</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-3a48d47e39b7de1f1ff82af3d9d1724473a766cbcbcec0490e7cc62df96006aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Age Factors</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiomyopathy, Hypertrophic - complications</topic><topic>Cardiomyopathy, Hypertrophic - genetics</topic><topic>Cardiomyopathy, Hypertrophic - mortality</topic><topic>Death, Sudden, Cardiac - epidemiology</topic><topic>Death, Sudden, Cardiac - etiology</topic><topic>Emergency and intensive care: neonates and children. Prematurity. Sudden death</topic><topic>Exercise - physiology</topic><topic>Female</topic><topic>Heart</topic><topic>Humans</topic><topic>Hypertension - etiology</topic><topic>Hypertension - mortality</topic><topic>Hypertrophic cardiomyopathy</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocarditis. Cardiomyopathies</topic><topic>Pedigree</topic><topic>Poland - epidemiology</topic><topic>Prognosis</topic><topic>Risk Factors</topic><topic>Sudden death</topic><topic>Syncope - etiology</topic><topic>Syncope - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dimitrow, Paweł Petkow</creatorcontrib><creatorcontrib>Chojnowska, Lidia</creatorcontrib><creatorcontrib>Rudziński, Tomasz</creatorcontrib><creatorcontrib>Piotrowski, Walerian</creatorcontrib><creatorcontrib>Ziółkowska, Lidia</creatorcontrib><creatorcontrib>Wojtarowicz, Andrzej</creatorcontrib><creatorcontrib>Wycisk, Anna</creatorcontrib><creatorcontrib>Dąbrowska-Kugacka, Alicja</creatorcontrib><creatorcontrib>Nowalany-Kozielska, Ewa</creatorcontrib><creatorcontrib>Sobkowicz, Bożena</creatorcontrib><creatorcontrib>Wróbel, Wojciech</creatorcontrib><creatorcontrib>Aleszewicz-Baranowska, Janina</creatorcontrib><creatorcontrib>Rynkiewicz, Andrzej</creatorcontrib><creatorcontrib>Łoboz-Grudzień, Krystyna</creatorcontrib><creatorcontrib>Marchel, Michał</creatorcontrib><creatorcontrib>Wysokiński, Andrzej</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dimitrow, Paweł Petkow</au><au>Chojnowska, Lidia</au><au>Rudziński, Tomasz</au><au>Piotrowski, Walerian</au><au>Ziółkowska, Lidia</au><au>Wojtarowicz, Andrzej</au><au>Wycisk, Anna</au><au>Dąbrowska-Kugacka, Alicja</au><au>Nowalany-Kozielska, Ewa</au><au>Sobkowicz, Bożena</au><au>Wróbel, Wojciech</au><au>Aleszewicz-Baranowska, Janina</au><au>Rynkiewicz, Andrzej</au><au>Łoboz-Grudzień, Krystyna</au><au>Marchel, Michał</au><au>Wysokiński, Andrzej</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>31</volume><issue>24</issue><spage>3084</spage><epage>3093</epage><pages>3084-3093</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Aims In hypertrophic cardiomyopathy (HCM), the following five risk factors have a major role in the primary prevention of sudden death (SD): family history of SD (FHSD), syncope, massive wall thickness (MWTh) &gt;30 mm, non-sustained ventricular tachycardia (nsVT) in Holter monitoring of electrocardiography, and abnormal blood pressure response to exercise (aBPRE). In HCM, as a genetic cardiac disease, the risk for SD may also exist from birth. The aim of the study was to compare the survival curves constructed for each of the five risk factors in a traditional follow-up model (started at the first presentation of a patient at the institution) and in a novel follow-up model (started at the date of birth). In an additional analysis, we compared the survival rate in three subgroups (without FHSD, with one SD, and with two or more SDs in a family). Methods and results A total of 1306 consecutive HCM patients (705 males, 601 females, mean age of 47 years, and 193 patients were &lt;18 years) evaluated at 15 referral centres in Poland were enrolled in the study. In a novel method of follow-up, all the five risk factors confirmed its prognostic power (FHSD: P = 0.0007; nsVT: P &lt; 0.0001; aBPRE: P = 0.0081; syncope: P &lt; 0.0001; MWTh P&gt; 0.0001), whereas in a traditional method, only four factors predicted SD (except aBPRE). In a novel model of follow-up, FHSD in a single episode starts to influence the prognosis with a delay to the fifth decade of life (P = 0.0007). Multiple FHSD appears to be a very powerful risk factor (P &lt; 0.0001), predicting frequent SDs in childhood and adolescence. Conclusion The proposed concept of a lifelong calculated follow-up is a useful strategy in the risk stratification of SD. Multiple FHSD is a very ominous risk factor with strong impact, predicting frequent SD episodes in the early period of life.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>20843960</pmid><doi>10.1093/eurheartj/ehq308</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2010-12, Vol.31 (24), p.3084-3093
issn 0195-668X
1522-9645
language eng
recordid cdi_proquest_miscellaneous_818402958
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Age Factors
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Cardiology. Vascular system
Cardiomyopathy, Hypertrophic - complications
Cardiomyopathy, Hypertrophic - genetics
Cardiomyopathy, Hypertrophic - mortality
Death, Sudden, Cardiac - epidemiology
Death, Sudden, Cardiac - etiology
Emergency and intensive care: neonates and children. Prematurity. Sudden death
Exercise - physiology
Female
Heart
Humans
Hypertension - etiology
Hypertension - mortality
Hypertrophic cardiomyopathy
Intensive care medicine
Male
Medical sciences
Middle Aged
Myocarditis. Cardiomyopathies
Pedigree
Poland - epidemiology
Prognosis
Risk Factors
Sudden death
Syncope - etiology
Syncope - mortality
title Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A47%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sudden%20death%20in%20hypertrophic%20cardiomyopathy:%20old%20risk%20factors%20re-assessed%20in%20a%20new%20model%20of%20maximalized%20follow-up&rft.jtitle=European%20heart%20journal&rft.au=Dimitrow,%20Pawe%C5%82%20Petkow&rft.date=2010-12-01&rft.volume=31&rft.issue=24&rft.spage=3084&rft.epage=3093&rft.pages=3084-3093&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehq308&rft_dat=%3Cproquest_cross%3E818402958%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=818402958&rft_id=info:pmid/20843960&rfr_iscdi=true